This article reviews key clinical and public health considerations surrounding recent tuberculosis (TB) cases reported in Maine, North Carolina, and California. Although TB remains relatively rare in the United States, it continues to cause more than 1 million deaths annually worldwide and poses ongoing risks, particularly for individuals with weakened immune systems or those who live or work in congregate settings...
Favorite
Community Based Organizations
Educators
General Public
Outreach Workers
2026
Recent weeks have seen a handful of new Tuberculosis (TB) cases reported in states including Maine, North Carolina and California. While TB is rare in the U.S., even a single active case warrants attention. This article provides an overview of what TB is & how it spreads. TB is caused by a bacterium (Mycobacterium tuberculosis) that typically attacks the lungs, forming lesions called “tubercles,” and can destroy lung tissue — severe disease can lead to respiratory failure...
Favorite
Community Based Organizations
Educators
General Public
Outreach Workers
2026
This information sheet provides a comprehensive overview of tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs but can involve other parts of the body. It distinguishes between Latent TB Infection (LTBI), which is asymptomatic and non-infectious, and active TB disease, which can be pulmonary (infectious) or extrapulmonary (non-infectious)...
Favorite
Educators
Nurses
Schools
Students
2026
Tuberculosis (TB), a contagious bacterial infection primarily affecting the lungs, remains a health risk in the U.S. Though cases declined for decades, recent increases — including ~10,347 cases in early data from 2024 — suggest testing and treatment of latent TB is needed more than ever. Testing is crucial both for diagnosing latent TB (where bacteria are present but symptoms are absent) and active TB disease (which is contagious and manifests symptoms)...
Favorite
Educators
General Public
Outreach Workers
Physicians
2026
Tuberculosis (TB) remains the world’s deadliest infectious disease and a major treatment challenge, especially in cases resistant to standard therapies. A new AI-powered tool developed by Tufts University researchers, called DECIPHAER (Decoding Cross-Modal Information of Pharmacologies via Autoencoders), seeks to advance TB treatment by elucidating exactly how drugs kill the bacterium at the cellular and molecular levels...
Favorite
Educators
Outreach Workers
Physicians
Researchers
2026
This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.
Favorite
Health Professionals
Policy Makers
Researchers
State Government Agencies
2025
This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB.
Favorite
Health Educators/Communicators
Health Professionals
Nurses
Physicians
2025
This video addresses the ongoing challenge of tuberculosis (TB) in Alaska, which has the highest TB rate in the United States. It emphasizes that TB can affect anyone and underscores the importance of awareness, testing, and treatment to help end TB in the state.
Favorite
At Risk Persons
General Public
Health Educators/Communicators
2025
This toolkit serves as a comprehensive resource for communities affected by tuberculosis. It offers practical tools and guidance to support TB advocacy, treatment, and care, with a focus on marginalized populations. It also provides strategies for addressing barriers to care, promoting patient-centered approaches, and advocating for policy changes to strengthen global TB prevention and control efforts...
Favorite
Educators
General Public
Health Educators/Communicators
Health Professionals
2025
This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies...
Favorite
General Public
Government Agencies
Health Educators/Communicators
Health Professionals
Physicians
Policy Makers
2025
This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB...
Favorite
Health Professionals
Policy Makers
Researchers
2024
This information sheet offers a concise overview of tuberculosis (TB), detailing its transmission, symptoms, and treatment.
Favorite
At Risk Persons
Health Educators/Communicators
Persons with TB
2024
This 30-minute podcast was created in recognition of World TB Day. In the recording, Dr. Zelalem Temesgen discusses TB, including information on TB diagnosis and management.
Favorite
Health Professionals
Medical and Nursing School Students
Nurses
Physicians
2024
In this 45-minute webinar, participants are introduced to the fundamentals of TB. Topics include modes of transmission, common symptoms, diagnostic testing protocols, treatment regimens, and more.
Favorite
Health Professionals
2024
This fact sheet is designed to assist clinicians, TB program staff, and individuals interested in understanding the role of compounding pharmacies in supporting the treatment of patients with TB disease or LTBI. The resource also includes compounding pharmacy website links.
Favorite
Nurses
Physicians
2024
